We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
all report title image

PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETER MARKET ANALYSIS

Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter Market, by Product Type (Normal Balloon Catheter, Drug Eluting Balloon Catheter, Cutting Balloon Catheter, and Scoring Balloon Catheter), by Balloon Material (Polyolefin copolymer (POC), Polyethylene (PE), and Polyethylene terephthalate (PET)), by End User (Hospitals and Ambulatory Surgical Centers) by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

  • Published In : Aug 2022
  • Code : CMI5194
  • Pages :180
  • Formats :
      Excel and PDF
  • Industry : Medical Devices

Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter MarketSize and Trends

The percutaneous transluminal coronary angioplasty (PTCA) balloon catheter market is estimated to be valued at US$ 2.2 Billion in 2022 and is expected to exhibit a CAGR of 8 % over the forecast period (2022-2030)

Figure 1. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter Market Value (US$ Mn), By Region, 2022

Market Trends: Increasing cardiovascular disease epidemiology worldwide is expected to boost the percutaneous transluminal coronary angioplasty (PTCA) market growth over the forecast period.

For instance, according to the data published in the Centers for Disease Control and Prevention in 2020, in the year 2020, about 20.1 million adults age 20 and older had cardiovascular diseases (about 7.2%), and about 2 in 10 deaths from cardiovascular diseases happened in adults less than 65 years old in U.S.

Figure 2. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter Market Share (%), By Product Type, 2022

Increasing product launches and approvals are expected to drive the growth of the percutaneous transluminal coronary angioplasty (PTCA) balloon catheter market over the forecast period.

For instance, in July 2021, MedAlliance, a medical technology company headquartered in Switzerland, had launched ORIGIN NC, two high-performance balloons for vessel preparation. ORIGIN SC is a semi-compliant (SC) PTCA with a very low crossing profile. Its sizes include 1.00 mm, 1.25 mm, 1.50 mm, and 1.75 mm balloon diameter to treat very small vessels and complex cases.

ORIGIN NC is a non-compliant (NC) PTCA balloon, combining high-pressure tolerance and controlled compliance with an optimal crossing profile for challenging cases.

Moreover, in August 2018, S3V Vascular Technologies Private Limited, a medical devices manufacturing company, launched Nextgen PTCA (Percutaneous Transluminal Coronary Angioplasty) Balloon Catheters.

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.